Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency in drug candidates. Also employed in research for designing nitric oxide synthase modulators due to the N-hydroxyamidine functional group. Shows potential in medicinal chemistry for optimizing bioavailability and metabolic stability in small molecule therapeutics.